CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-06 | SOLAND DANIEL B Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-06 | SOLAND DANIEL B Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-06 | HARRIGAN EDMUND Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-06 | HARRIGAN EDMUND Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-06 | Daly James M Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-06 | Daly James M Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-06-06 | Brege Laura Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2018-04-18 | Baity Glenn EVP AND GC | Grant or award · Stock Option (right to buy) | +28,125 | 28,125 | ||
| 2018-04-18 | YOUNG TODD S. EVP AND CFO | Grant or award · Stock Option (right to buy) | +28,125 | 28,125 | ||
| 2018-04-18 | YANG MICHAEL J. EVP AND CCO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2018-04-18 | Stankovic Srdjan R. EVP | Grant or award · Stock Option (right to buy) | +71,250 | 71,250 | ||
| 2018-04-18 | DAVIS STEPHEN PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2018-03-02 | SOLAND DANIEL B Director | Purchase | +3,000 | $22.52 | $68K | 10,000 |
| 2018-03-01 | SOLAND DANIEL B Director | Purchase | +2,000 | $23.02 | $46K | 2,000 |
| 2018-03-01 | SOLAND DANIEL B Director | Purchase | +3,000 | $24.09 | $72K | 5,000 |
| 2018-03-01 | SOLAND DANIEL B Director | Purchase | +2,000 | $24.52 | $49K | 7,000 |
| 2018-01-29 | Baity Glenn EVP AND GC | Sale | −36,558 | $32.39 | $1.2M | 83,734 |
| 2018-01-10 | Baity Glenn EVP AND GC | Option exercise | +50,179 | $2.18 | $109K | 120,292 |
| 2018-01-10 | Baity Glenn EVP AND GC | Option exercise · Stock Option (right to buy) | −50,179 | 0 | ||
| 2018-01-02 | Baity Glenn EVP AND GC | Option exercise | +74,321 | $2.18 | $162K | 144,434 |
Page 47 of 63 · 1,260 trades